Caribou Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRBU and other ETFs, options, and stocks.About CRBU
Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology.
CEORachel E. Haurwitz
CEORachel E. Haurwitz
Employees147
Employees147
HeadquartersBerkeley, California
HeadquartersBerkeley, California
Founded2011
Founded2011
Employees147
Employees147
CRBU Key Statistics
Market cap176.65M
Market cap176.65M
Price-Earnings ratio-1.10
Price-Earnings ratio-1.10
Dividend yield—
Dividend yield—
Average volume861.45K
Average volume861.45K
High today$1.89
High today$1.89
Low today$1.82
Low today$1.82
Open price$1.87
Open price$1.87
Volume671.29K
Volume671.29K
52 Week high$3.54
52 Week high$3.54
52 Week low$0.66
52 Week low$0.66
Stock Snapshot
The current Caribou Biosciences(CRBU) stock price is $1.89, with a market capitalization of 176.65M. The stock trades at a price-to-earnings (P/E) ratio of -1.10.
On 2025-12-10, Caribou Biosciences(CRBU) stock moved within a range of $1.82 to $1.89. With shares now at $1.89, the stock is trading +4.1% above its intraday low and 0.0% below the session's peak.
Trading activity shows a volume of 671.29K, compared to an average daily volume of 861.45K.
Over the past 52 weeks, Caribou Biosciences(CRBU) stock has traded between a high of $3.54 and a low of $0.66.
Over the past 52 weeks, Caribou Biosciences(CRBU) stock has traded between a high of $3.54 and a low of $0.66.
Analyst ratings
100%
of 8 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own CRBU. This list is generated using Robinhood data, and it’s not a recommendation.